Literature DB >> 8683601

Crystal structure of human trypsin 1: unexpected phosphorylation of Tyr151.

C Gaboriaud1, L Serre, O Guy-Crotte, E Forest, J C Fontecilla-Camps.   

Abstract

The X-ray structure of human trypsin 1 has been determined in the presence of diisopropyl-phosphofluoridate by the molecular replacement method and refined at a resolution of 2.2 A to an R-factor of 18%. Crystals belong to the space group P4, with two independent molecules in the asymmetric unit packing as crystallographic tetramers. This study was performed in order to seek possible structural peculiarities of human trypsin 1, suggested by some striking differences in its biochemical behavior as compared to other trypsins of mammalian species. Its fold is, in fact, very similar to those of the bovine, rat and porcine trypsins, with root-mean-square differences in the 0.4 to 0.6 A range for all 223 C alpha positions. The most unexpected feature of the human trypsin 1 structure is in the phosphorylated state of tyrosine residue 151 in the present X-ray study. This feature was confirmed by mass spectrometry on the same inhibited sample and also on the native enzyme. This phosphorylation strengthens the outstanding clustering of highly negative or highly positive electrostatic surface potentials. The peculiar inhibitory behaviour of pancreatic secretory trypsin inhibitors of the Kazal type on this enzyme is discussed as a possible consequence of these properties. A charged surface loop has also been interpreted as an epitope site recognised by a monoclonal antibody specific to human trypsin 1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683601     DOI: 10.1006/jmbi.1996.0376

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  21 in total

Review 1.  Hereditary pancreatitis: new insights into acute and chronic pancreatitis.

Authors:  D C Whitcomb
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Biochemical models of hereditary pancreatitis.

Authors:  Miklós Sahin-Tóth
Journal:  Endocrinol Metab Clin North Am       Date:  2006-06       Impact factor: 4.741

3.  Human mesotrypsin exhibits restricted S1' subsite specificity with a strong preference for small polar side chains.

Authors:  Edit Szepessy; Miklós Sahin-Tóth
Journal:  FEBS J       Date:  2006-06-05       Impact factor: 5.542

Review 4.  Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Authors:  Niels Teich; Jonas Rosendahl; Miklós Tóth; Joachim Mössner; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

Review 5.  Genetic mechanisms underlying the pathogenesis of tropical calcific pancreatitis.

Authors:  Swapna Mahurkar; D Nageshwar Reddy; G Venkat Rao; Giriraj Ratan Chandak
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

6.  New enzyme lineages by subdomain shuffling.

Authors:  K P Hopfner; E Kopetzki; G B Kresse; W Bode; R Huber; R A Engh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Direct proton magnetic resonance determination of the pKa of the active center histidine in thiolsubtilisin.

Authors:  Ara Kahyaoglu; Frank Jordan
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

Review 8.  Sodium and T1rho MRI for molecular and diagnostic imaging of articular cartilage.

Authors:  Arijitt Borthakur; Eric Mellon; Sampreet Niyogi; Walter Witschey; J Bruce Kneeland; Ravinder Reddy
Journal:  NMR Biomed       Date:  2006-11       Impact factor: 4.044

9.  A common African polymorphism abolishes tyrosine sulfation of human anionic trypsinogen (PRSS2).

Authors:  Zsolt Rónai; Heiko Witt; Olga Rickards; Giovanni Destro-Bisol; Andrew R M Bradbury; Miklós Sahin-Tóth
Journal:  Biochem J       Date:  2009-02-15       Impact factor: 3.857

10.  Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y.

Authors:  Richárd Szmola; Miklós Sahin-Tóth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.